Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten

Japan Display Inc. (OTCMKTS:JNNDF) Short Interest Update - Defense World

Defense World

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest Update - Defense World

Defense World

Novak & Powell Financial Services Inc. Invests $652000 in SPDR S&P International Dividend ETF (NYSEARCA:DWX) - Defense World

Defense World

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research - br.ADVFN.com

br.ADVFN.com

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists ... - br.ADVFN.com

br.ADVFN.com

New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences - The Globe and Mail

The Globe and Mail

Bright Minds Biosciences Announces Upcoming AGM - TipRanks.com - TipRanks

TipRanks

Bright Minds Biosciences Reports Financial Downturn - TipRanks.com - TipRanks

TipRanks

ILMN: 3 Biotech Stocks to Buy in 2024 - StockNews.com

StockNews.com

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And M - Benzinga

Benzinga

Mind Medicine sends psychedelic stocks higher on LSD drug - Seeking Alpha

Seeking Alpha

Envestnet Asset Management Inc. Increases Stock Position in Ball Co. (NYSE:BALL) - American Banking and Market News

American Banking and Market News

Bright Minds trims losses, but deficit grows - Green Market Report

Green Market Report

Short sales on the TSX: What bearish investors are betting against - The Globe and Mail

The Globe and Mail

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences ... - Benzinga

Benzinga

PurMinds Appoints Leading Drug Designer, Dr. Alan Kozikowski, to Chief Scientific Officer and Appoints Pharma ... - Newsfile

Newsfile

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More ... - Benzinga

Benzinga

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More - ATAI L - Benzinga

Benzinga

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Compass ... - Benzinga

Benzinga

PurMinds Appoints Leading Drug Designer to Scientific Advisory Board - Microdose Psychedelic Insights

Microdose Psychedelic Insights

Serotonin agonist BMB-101 found safe, well-tolerated in healthy... - Dravet Syndrome News

Dravet Syndrome News

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More - Markets Insider

Markets Insider

How Enthea is Revolutionizing Psychedelic-Assisted Therapy Accessibility feat. Sherry Rais - Psychedelic Spotlight

Psychedelic Spotlight

Bright Minds completes first-in-human study of BMB-101 - Clinical Trials Arena

Clinical Trials Arena

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound ... - GlobeNewswire

GlobeNewswire

Bright Minds Announces Effective Date of Share Consolidation - GlobeNewswire

GlobeNewswire

Bright Minds Announces Proposed Share Consolidation - Yahoo Finance

Yahoo Finance

Perfect time to invest in psychedelics before Big Pharma makes its move: VC fund manager - Proactive Investors UK

Proactive Investors UK

Psychedelics Stocks to Watch | INN - Investing News Network

Investing News Network

Who's Suing Whom: April 19, 2023 - Business in Vancouver

Business in Vancouver

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research - Psychedelic Alpha

Psychedelic Alpha

Bright Minds' Dravet syndrome treatment shows promise in trial |... - Dravet Syndrome News

Dravet Syndrome News

PsychedelicScape 2023: Psychedelic Companies Building the Future - NuWire Investor

NuWire Investor

Most Funded Psychedelic Companies 2023 - NuWire Investor

NuWire Investor

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit ... - Yahoo Canada Sports

Yahoo Canada Sports

Bright Minds Biosciences Announces Resignation of Board Member - Yahoo Canada Sports

Yahoo Canada Sports

Phoenix: a global destination for bioscience and healthcare innovators - Nature.com

Nature.com

Post-traumatic Stress Disorder Clinical Trials Pipeline Analysis: 25+ Companies are Working to Improve the Treatment ... - GlobeNewswire

GlobeNewswire

Horticulture's Yencho and Pecota Win NC State's Innovator of the Year Award - NC State CALS

NC State CALS

Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket By Benzinga - Investing.com UK

Investing.com UK

Dow, S&P 500 Edge Lower Following Powell's Comments - Markets Insider

Markets Insider

Psychedelic Drug Therapy May Help Treat Alcohol Addiction - NYU Langone Health

NYU Langone Health

Psychedelic Bulletin #115 - Mydecine Looks Set to Shutter; MindMed Gains 'Meme Stock' Status; atai 'Streamlilnes ... - Psychedelic Alpha

Psychedelic Alpha

Bright Minds Biosciences Comments on Recent Trading Activity - GlobeNewswire

GlobeNewswire

Psychedelic Therapeutics Market worth $ 8.31 billion by 2028 - Exclusive Report by InsightAce Analytic - PR Newswire

PR Newswire

BioSpace Movers & Shakers: Evommune, Maravai, Aptose & More - BioSpace

BioSpace

The Four Psychedelics ETFs Capturing Investor Attention - Psychedelic Spotlight

Psychedelic Spotlight

Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type ... - GlobalData

GlobalData

Consolidating Plant Medicine, Permaculture and Indigenous Wisdom With Colette Condorcita, Decriminalize ... - Psychedelic Spotlight

Psychedelic Spotlight

Elon Musk Tweet Excites Psychedelic CEOs - Psychedelic Spotlight

Psychedelic Spotlight